Barrx Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Barrx's estimated annual revenue is currently $5.3M per year.(i)
  • Barrx's estimated revenue per employee is $251,000

Employee Data

  • Barrx has 21 Employees.(i)
  • Barrx grew their employee count by -19% last year.

Barrx's People

NameTitleEmail/Phone
1
VP RAQAReveal Email/Phone
2
Sr Manager Electronics Mfg/Svc OperationsReveal Email/Phone
3
Assoc. Territory ManagerReveal Email/Phone
4
Event ManagerReveal Email/Phone
5
Global Market DevelopmentReveal Email/Phone
6
Eng Tech R&DReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is Barrx?

Covidien GI solutions (formerly BÂRRX Medical, Inc.) is located in Sunnyvale, California. GI Solutions has developed a Radiofrequency bipolar ablation technology that treats Barrett's esophagus as well as other gastrointestinal diseases like GAVE and Radiation Proctitis. The company has a direct sales organization in the US and independent distributors outside the US. At BÂRRX Medical we are committed to the ongoing research and treatment of Barrett's esophagus in order to improve the quality of life of patients diagnosed with the disease.

keywords:N/A

N/A

Total Funding

21

Number of Employees

$5.3M

Revenue (est)

-19%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Barrx News

2022-04-13 - Aspirus Iron River now offers advanced acid reflux treatment

The RFA procedure Fanous is now performing at Aspirus Iron River Hospital uses the BARRX system, which is designed to treat gastrointestinal...

2022-03-30 - Se inauguró en el Hospital de Clínicas el equipo “Barrx”, único en el país para tratar el esófago de Barrett

El gastroenterólogo argentino Cecilio Cerisoli dijo que se trata de una “enfermedad letal” ligada al cáncer aunque “muy poco frecuente”;...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.7M21-9%N/A
#2
$2.1M215%N/A
#3
$2.1M215%N/A
#4
$2.1M21-30%N/A
#5
N/A21-50%N/A